30th June 2026, Tuesday

TechPharus

Latest Posts

HealthTech News

  • New mechanism behind breast cancer metastasis uncovered
    on June 30, 2026 at 4:20 pm

    Researchers at Umeå University show that the protein METTL3 helps breast cancer cells spread. By regulating the release of molecules, METTL3 makes it easier for tumors to invade surrounding tissue and form metastases. The discovery reveals a previously unknown function of METTL3 and could influence future cancer treatments. The study has been published in Science Advances.

  • Nutrition apps can help build healthy habits. For some users, their gaming features carry risks
    on June 30, 2026 at 4:20 pm

    Green means go, red means stop. Trophies or confetti come with good performance, and people who fall behind get nudged to do better.

  • Newer insulin may reduce low blood sugar in youth with type 1 diabetes
    on June 30, 2026 at 4:00 pm

    A trial led by University of Pittsburgh researchers and published today in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins are as effective as insulin analogs in low-resource settings.

  • Extreme temperatures increase emergency department visits among people with dementia, study finds
    on June 30, 2026 at 4:00 pm

    Exposure to extreme heat and cold is associated with an increased risk of emergency department (ED) visits among people living with dementia, according to preliminary research presented at the European Academy of Neurology (EAN) Congress 2026. The findings provide new evidence that environmental factors can have measurable effects on the health of people with neurological disorders.

  • African genetic data could change how essential medicines are prescribed
    on June 30, 2026 at 3:40 pm

    The dosage information for drugs used in HIV treatment, malaria, cancer care, pain management and transplantation is largely based on data from European patients and fails to include vital information about how essential drugs work in diverse African populations. A Wits-led policy brief shows that more than 10% of essential medicines may require pharmacogenomic guidance. Pharmacogenomics is the study of how a person’s genetic makeup affects their body’s response to medications.